Physician profile
Jennifer Rebecca Hill
NPI 1932390150
$12,725.38
in general payments reported to CMS, 2019-2025
18 companies · $5,286 in 2025
The $5,286 reported for 2025 was more than what 87% of Urogynecology and Reconstructive Pelvic Surgery (Urology) providers received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $271 · 2021: $1,244 · 2022: $176 · 2023: $1,479 · 2024: $3,664 · 2025: $5,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $2,709 · Travel and Lodging: $2,356 · Honoraria: $258 · Gift: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $2,708.69 |
| Travel and Lodging | $2,355.96 |
| Honoraria | $257.63 |
| Gift | $106.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $5,926.03 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $5,431.97 | 2020-2025 | Axonics, Solyx Sis System |
| Astellas Pharma US INC | $677.03 | 2019-2022 | |
| Intuitive Surgical, INC. | $220.46 | 2025 | |
| Caldera Medical, INC | $106.70 | 2023 | Desara |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.44 | 2019 | |
| Sumitomo Pharma America, INC. | $45.41 | 2023 | Gemtesa |
| Abbvie INC. | $36.01 | 2022-2023 | |
| Davol INC. | $34.98 | 2022 | |
| Therapeuticsmd, INC. | $33.34 | 2019 | |
| Allergan, INC. | $19.50 | 2019 | |
| Ethicon US, LLC | $16.32 | 2021 | |
| Daiichi Sankyo INC. | $15.31 | 2019 | |
| Urovant Sciences INC | $14.91 | 2022 | |
| Geistlich Pharma, North America, INC. | $13.08 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $12.43 | 2019 | |
| Coloplast Corp | $12.34 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.